A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Clinical trial NCT03371017 · COMPLETED
Trial details
- NCT number
- NCT03371017
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2024-10-23
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.